APA-viite

Pershing, S., Talwar, N., Armenti, S. T., Grubbs, J., Rosenthal, J. M., Dedania, V. S., & Stein, J. D. (2019). Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept. Am J Ophthalmol.

Chicago-tyylinen lähdeviittaus

Pershing, Suzann, Nidhi Talwar, Stephen T. Armenti, Joseph Grubbs, Julie M. Rosenthal, Vaidehi S. Dedania, ja Joshua D. Stein. "Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept." Am J Ophthalmol 2019.

MLA-viite

Pershing, Suzann, et al. "Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept." Am J Ophthalmol 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.